CIRM Approves $662M Regen Med Funding, Largest in its History
The California agency is hoping to accelerate the cell & gene therapy industry amid uncertainty about federal funding.
Business
REPROCELL Receives Commercialization Award from Maryland Stem Cell Research Fund to Advance Universal, Hypoimmune iPSC Platforms
The award will fund REPROCELL’s development of clinical-grade lines and a modular gene insertion platform designed to improve scalability, regulatory readiness, and access to off-the-shelf cell therapies.
Cellares Joins New American Industrial Alliance, Advancing U.S. Biopharmaceutical Manufacturing Independence
The automated CDMO is hoping to reduce America's reliance on foreign biomanufacturing for advanced therapies.
Maryland Stem Cell Research Commission Announces $12.6M For Regenerative Medicine, Next Funding Cycle Taking Applications Now
The 38 projects include work in diabetes, cancer, Parkinson's disease, stroke, sickle cell disease, chronic pain, and cardiovascular, bone, blood, digestive, and neurological disorders
BioStem Technologies Receives 5 Patents for Placental Allografts
The 4 US and 1 European patents cover the design and manufacturing of the company's placental therapies. The company is targeting various applications across orthopedics, urology, and wound care.
Dark Horse Consulting Group and KunTuo Team Up To Accelerate Cell & Gene Therapy Trials In China
The partnership combines Dark Horse's regulatory and development consulting with KunTuo's on-the-ground clinical trial execution to help companies launch studies faster and generate data to support regulatory submissions.
Cellular Intelligence, Backed by Zuckerberg, Acquires Novo Nordisk’s Parkinson’s Cell Therapy Tech
Cellular Intelligence will use its AI platform to speed the clinical development and scalable manufacturing of a Phase 1/2 stem cell-derived Parkinson’s therapy acquired from Novo Nordisk, which also took an equity...
Latus Bio Nabs $97 Million to Continue Neurodegenerative Gene Therapy Pipeline
The funding will support Latus Bio’s lead gene therapy programs in Huntington’s and CLN2 disease while advancing its low-dose AAV delivery platform designed to make gene therapies safer, more scalable, and accessible...
Regeneron Nabs Deal with White House, New Gene Therapy Will Be Free
Regeneron said it will reduce Medicaid and future U.S. drug prices in line with other developed countries, enable direct discounted purchases of Praluent through TrumpRx.gov, and continue investing in domestic R&D and...
Mesoblast Acquires Mayo Clinic’s Chimeric Antigen Receptor (CAR) Platform to Enhance its Stem Cell Therapies
Mesoblast has secured exclusive global rights to a CAR technology platform to engineer its MSC therapies for more precise targeting and greater potency in inflammatory and autoimmune diseases, including bowel disease and...
